awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37773275-A18773AE-66D6-4D98-A257-AB693E75CBCF
Q37773275-A18773AE-66D6-4D98-A257-AB693E75CBCF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37773275-A18773AE-66D6-4D98-A257-AB693E75CBCF
MAGE A3 antigen-specific cancer immunotherapeutic.
P2860
Q37773275-A18773AE-66D6-4D98-A257-AB693E75CBCF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37773275-A18773AE-66D6-4D98-A257-AB693E75CBCF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4ebf62821007c3a6a46b83a3975e75f51435b981
P2860
Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer.